Epstein David R bought AGMB
October 8, 2026 · Form 4 insider transaction
Epstein David R bought 5,000 shares of AgomAb Therapeutics NV at $8.90 per share, a transaction worth $44.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$8.90
Total value
$44.5K
InsiderEpstein David R
RoleDirector
SecurityCommon shares
Transaction codeP: Open-market purchase
Transaction dateOctober 8, 2026
Filing dateOctober 9, 2026
Shares owned after15,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The common shares may be represented by American Depositary Shares, each of which currently represents one common share.